Navigating the complexities of immunotherapy: unraveling novel targets & pathways

Lauren Coyle, Editor, Immuno-Oncology Insights, interviews Lars van der Veen, Founder and CTO of iOnctura to discuss the evolving landscape of novel targets and pathways in the I-O space. 

Please enter your email to access content Read now